0001680132-26-000006
SEC filingQ3 FY2026 delivered zero revenue after sub-lease termination, widened operating losses from reduced professional fees, and positive net income driven by other income from debt settlement for unpaid rent, amid critically low cash and working capital deficit signaling ongoing capital needs.
Cannabis Suisse Corp. (CSUI) reported zero revenue for Q3 FY2026 ended February 28, 2026, a complete elimination from $7,500 in the prior year quarter. This drop stems directly from the termination of the Company's sole sub-lease on February 28, 2025, which eliminated both top-line recognition and associated costs of goods sold. Consequently, gross profit also reached $0, down -100% from $144 year-over-year, leaving no margin contribution from operations.
Operating expenses declined overall, mainly due to lower professional fees as noted in management's discussion, yet the operating loss still expanded -3.9% to -$69,394 from -$66,788. This reflects the absence of revenue to offset fixed cost structures in a cannabis-related microcap facing market and regulatory headwinds. The business context highlights cost control efforts amid no sales activity, but persistent general and administrative burdens prevented breakeven at the operating level.
Looking forward, the path hinges on securing external capital amid going concern considerations. The combination of no revenue runway, ongoing cash burn, and balance sheet pressures positions CSUI as highly sensitive to funding availability and potential debt restructurings, consistent with the filing's risk disclosures that actual results may differ materially from expectations.